uniQure
QURE
#5384
Rank
C$1.87 B
Marketcap
C$30.16
Share price
2.06%
Change (1 day)
191.98%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of September 2025 : C$0.96 Billion

According to uniQure's latest financial reports the company has C$0.96 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.52 B-35.65%
2023-12-31C$0.81 B71.17%
2022-12-31C$0.47 B-32.46%
2021-12-31C$0.70 B126.99%
2020-12-31C$0.31 B-36.71%
2019-12-31C$0.49 B54.2%
2018-12-31C$0.31 B59.69%
2017-12-31C$0.20 B12.53%
2016-12-31C$0.17 B-42.08%
2015-12-31C$0.30 B309.37%
2014-12-31C$75.1 M114.58%
2013-12-31C$34.99 M10019.15%
2012-12-31C$0.34 M-76.15%
2011-12-31C$1.45 M-93.89%
2010-12-31C$23.74 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
C$13.08 B 1,260.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$41.02 M-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
C$0.10 B-88.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
C$2.59 B 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$14.47 B 1,405.51%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
C$2.04 B 112.87%๐Ÿ‡บ๐Ÿ‡ธ USA